EUVIMEDEUVIMED entdecken
Crossref

Reducing Research Harms: Analysis and Recommendations for Researching Schedule I Substances Under the HALT Fentanyl Act

Alaina M. Jaster, Joseph Hennessey, Tanner L. Anderson, Anna Tsyrulnikov, Amartya Pradhan, Gina Giorgio, Elijah Z. Ullman

Journal of Science Policy & Governance · 06.07.2026 · 1 (28)

DOI: 10.38126/jspg280109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Science Policy & Governance, online erschienen am 06.07.2026. Verfasst von Alaina M. Jaster und 6 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Research on Schedule I substances in the United States remains heavily restricted by the regulatory structure imposed by the Controlled Substances Act (CSA). This regulatory system creates significant Research Harm, which can be defined as the restriction or deterrence of legitimate scientific inquiry arising from governmental actions, such as regulatory controls or criminal prohibitions that limit researchers’ access to or use of substances for scientific investigation. The barriers identified in this policy brief, including lengthy Drug Enforcement Administration (DEA) registration timelines, inconsistent guidance, and confusion around policies, limit access to substances with emerging therapeutic potential such as psilocybin, MDMA, cannabis, and DOI. The 2025 HALT Fentanyl Act introduces important procedural improvements, such as expedited registration, shared institutional access, and limited allowances for synthesis, but leaves key issues in regulatory processes unresolved. To ensure scientific progress and protect public health, we recommend further reforms, including revising interpretations of medical utility,, conducting periodic evidence reviews, and establishing a specific scheduling framework that allows easy access to substances for research

Zitieren

APA

Jaster, A. M., Hennessey, J., Anderson, T. L., Tsyrulnikov, A., Pradhan, A., Giorgio, G., & Ullman, E. Z. (2026). Reducing Research Harms: Analysis and Recommendations for Researching Schedule I Substances Under the HALT Fentanyl Act. Journal of Science Policy & Governance, 1(28). https://doi.org/10.38126/jspg280109

Vancouver

Jaster AM, Hennessey J, Anderson TL, Tsyrulnikov A, Pradhan A, Giorgio G, et al. Reducing Research Harms: Analysis and Recommendations for Researching Schedule I Substances Under the HALT Fentanyl Act. Journal of Science Policy & Governance. 2026;1(28). doi:10.38126/jspg280109

BibTeX
@article{Jaster2026,
  author = {Jaster, Alaina M. and Hennessey, Joseph and Anderson, Tanner L. and Tsyrulnikov, Anna and Pradhan, Amartya and Giorgio, Gina and Ullman, Elijah Z.},
  title = {Reducing Research Harms: Analysis and Recommendations for Researching Schedule I Substances Under the HALT Fentanyl Act},
  journal = {Journal of Science Policy & Governance},
  year = {2026},
  volume = {1},
  number = {28},
  doi = {10.38126/jspg280109}
}
Kostenlos starten →